Abstract
In view of the importance of liver tests in the follow-up of patients under treatment with corticosteroid hormones, 20 mg of prednisolone were given by mouth to normal volunteers for 4 days and hepatic function was assessed before and during treatment. Despite significant falls in plasma cortisol and serum bilirubin concentrations, the galactose elimination capacity, the BSP tests, and the urinaryd-glucaric acid output remained essentially unchanged. Consequently no pharmacological effect of this corticosteroid hormone on the examined tests could be detected.
Similar content being viewed by others
References
Peterson RE: Metabolism of adrenocorticosteroids in man. Ann NY Acad Sci 82:846–853, 1959
Sandberg AA, Slaunwhite WR: Differences in metabolism of prednisolone-C14 and cortisol-C14. J Clin Endocrin 17:1040–1050, 1957
Tygstrup N: Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest 18 (Suppl 95):118–125, 1966
Imesch B, Häcki W, Bircher J: Was misst die BSP-Retention? Schweiz Med Wochenschr 103:397–403, 1973
Wheeler HO, Meltzer JI, Bradley SE: Biliary transport and hepatic storage of sulfobromophthalein sodium in the unanesthetized dog, in normal man, and in patients with hepatic disease. J Clin Invest 39:1131–1144, 1960
Preisig R, Williams R, Sweeting J, Bradley SE: Changes in sulfobromophthalein transport and storage by the liver during viral hepatitis in man. Am J Med 40:170–183, 1966
Hjelm M: A methodological study of the enzymatic determination of galactose in human whole blood, plasma and erythrocytes with galactose oxidase. Clin Chim Acta 15:87–96, 1967
Michaëlsson M, Nosslin B, Sjölin S: Plasma bilirubin determination in the newborn infant. A methodological study with special reference to the influence of hemolysis. Pediatrics 35:925–931, 1965
Clark BR, Rubin RT, Poland RE: Modification of new fluorometric method for serum and urine cortisol. Biochem Med 5:177–179, 1971
Szasz G: A kinetic photometric method for serum γ-glutamyl transpeptidase. Clin Chem 15:124–136, 1969
Richterich R: Klinische Chemie. Basel, S Karger Verlag, 1971
Marsh CA: Metabolism of D-glucuronolactone in mammalian systems. Biochem J 86:77–86, 1963
Diem K, Lentner C: Wissenschaftliche Tabellen. Documenta Geigy. Basel, JR Geigy AG, 1968
Hunter J, Maxwell JD, Carella M, Stewart DA, Williams R: Urinary D-glucaric acid excretion as a test for hepatic enzyme induction in man. Lancet 1:572–575, 1971
Williams R, Hunter J, Maxwell JD: Measurement of hepatic enzyme induction in man. Use ofd-glucaric acid excretion test. The Liver. Quantitative Aspects of Structure and Function. Basel, S Karger Verlag, 1973, pp 224–231
Gans JH, McEntee K: Comparative effects of prednisolone and thyroid hormone on bile secretion in the dog. Am J Physiol 201:577–581, 1961
Macarol V, Morris TQ, Baker KJ, Bradley SE: Hydrocortisone choleresis in the dog. J Clin Invest 49:1714–1723, 1970
Zsigmond G, Solymoss B: Effect of spironolactone, pregnenolone-16α-carbonitrile and cortisol on the metabolism and biliary excretion of sulfobromophthalein and phenol-3,6-dibromophthalein disulfonate in rats. J Pharmacol Exp Ther 183:499–507, 1972
Keiding S, Andreasen PB, Fauerholdt L: Effect of phenobarbital induction on galactose elimination capacity in the rat. Biochem Pharmacol 22:2293–2297, 1973
Simmons CJ, Davis M, Dordoni B, Williams R: Urinaryd-glucaric acid assay by an improved enzymatic procedure. Clin Chim Acta 51:47–51, 1974
Remmer H: Die Verstärkung der Abbaugeschwindigkeit von Evipan durch Glykokortikoide. Arch Exper Path Pharmakol 233:184–191, 1958
Author information
Authors and Affiliations
Additional information
Supported by the Swiss National Foundation for Scientific Research.
Rights and permissions
About this article
Cite this article
Weiersmüller, A., Colombo, J.P. & Bircher, J. The influence of prednisolone on hepatic function in normal subjects. Digest Dis Sci 22, 424–428 (1977). https://doi.org/10.1007/BF01071890
Issue Date:
DOI: https://doi.org/10.1007/BF01071890